The U.S. District Court for the District of Massachusetts has allowed part of the U.S. government’s claims to proceed against Regeneron Pharmaceuticals for allegedly funneling millions of dollars to the Chronic Disease Fund (CDF), an independent charitable foundation, to subsidize copays for the company’s drug Eylea. 

The court ruled on both sides’ motions for partial summary judgment, finding there was enough evidence for the government to attempt to prove a causal connection between the donations and kickbacks received by providers.